The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,682,718 in first-year total cost, median $841,359.
Most frequent study sections
- Special Emphasis Panel[ZAG1 ZIJ-J (M2)]2
Most frequent institutions
- UNIVERSITY OF TEXAS HLTH SCIENCE CENTER1
- UT SOUTHWESTERN MEDICAL CENTER1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2024 | RESTOR [Rapamycin and Everolimus Study Towards Older Rejuvenation]: An exploratory PK/PD study of mTOR inhibition in older human subjects1U01AG089242-01 | GINSBURG, BRETT CKELLOGG, DEAN LKRAIG, ELLEN | UNIVERSITY OF TEXAS HLTH SCIENCE CENTER, TX | $1,064,317 | ZAG1 |
| 2024 | Pharmacokinetics (PK) and Pharmacodynamics (PD) Characterization of mTOR Inhibitors in Older Adults1U01AG081450-01A1 | DUNN, ALLISONSHU, YANTIMOFTE, IRINA | UT SOUTHWESTERN MEDICAL CENTER, TX | $618,401 | ZAG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.